Mark For: ORANET® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88648413 |
Registration Number | 6214304 |
Mark Literal Elements | ORANET |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED 2020-01-15 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Michael R Rizo |
Attorney Docket Number | 629.422.33 |
2012-01-01 | Date of First Use |
2012-01-01 | Date of Use In Commerce |
2019-10-09 | Application Filed |
2019-10-15 | Status: Live/Pending |
2019-10-21 | Location: TMEG LAW OFFICE 101 |
2019-10-21 | Transaction Date |
2020-01-15 | Location: TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED |
2020-01-15 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
2020-12-08 | Trademark Registered |
Party: | Ora, Inc. |
Address | 300 Brickstone Square Andover, MASSACHUSETTS UNITED STATES 01810 |
Legal Entity Type | Corporation |
Legal Entity State | MASSACHUSETTS |
Drawing | JPEG | 2019-10-09 |
Specimen | JPEG | 2019-10-09 |
TEAS RF New Application | MULTI | 2019-10-09 |
Preliminary Amendment | APPLICATION/XML | 2019-10-15 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-10-22 |
Offc Action Outgoing | MULTI | 2020-01-15 |
XSearch Search Summary | APPLICATION/XML | 2020-01-15 |
IC 044. US 100 101. G & S: providing medical and pharmaceutical information in the fields of ophthalmology, clinical trials, and preclinical trials. FIRST USE: 20120101. FIRST USE IN COMMERCE: 20120101
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | providing medical and pharmaceutical information in the fields of ophthalmology, clinical trials, and preclinical trials |
GS0441 | providing medical and pharmaceutical information in the fields of ophthalmology, clinical trials, and preclinical trials, namely, providing clinical trial site selection and clinical trial feasibility information using a global network and database of vetted clinical research sites, including providing information on required patient population, resource dedication, and enrollment timeframes |
Description | Date | Proceeding Number |
---|---|---|
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-01-15 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-01-15 | 80813 |
NON-FINAL ACTION E-MAILED | 2020-01-15 | 6325 |
ASSIGNED TO EXAMINER | 2020-01-14 | 80813 |
ASSIGNED TO LIE | 2019-10-21 | 70629 |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2019-10-21 | 70629 |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2019-10-15 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-15 | |
NEW APPLICATION ENTERED IN TRAM | 2019-10-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.